The apoptosis-inducing Fas receptor has been shown to be down-regulated in various types of tumors, while its ligand (FasL) appears to be frequently up-regulated. Here we provide evidence that there is a strong selective pressure in vivo against Fas-expressing, tumorigenic NIH3T3 cells, favoring survival, proliferation and eventually tumor formation by Fas-negative cells. Importantly, re-expression of Fas in these cells results in either the complete abolishment of tumor development, or in a signi®cant extenuation of the latency period of tumor outgrowth. In addition, we found that environmental conditions which prevail during tumorigenesis, such as limiting amounts of survival factors and the lack of cell adhesion, are markedly sensitizing tumor cells to Fas-mediated suicide. Our data suggest that in addition to T cell-mediated immune responses, mechanisms of Fas-dependent tissue turnover are also centrally implicated in tumor cell clearance.
Introduction
Tumor growth is a result of deregulated tissue homeostasis which is maintained through the delicate balance of cell growth and apoptosis (Thompson, 1995) . While survival signals are delivered by growth factors that actively stimulate proliferation and suppress default death pathways, cell death is eciently triggered by dedicated receptors. One very potent death receptor is Fas (CD95, Apo-1) which upon binding its ligand (FasL) can rapidly induce apoptosis by recruiting and activating caspase-8. Caspase-8 then initiates apoptosis by subsequent cleavage of downstream eector caspases, such as caspase-3, -6 and 7 (Nagata, 1997) . The central role of Fas in lymphocyte homeostasis, during which activated peripheral T cells are deleted by a Fasdependent mechanism, is well established (Abbas, 1996; Watanabe-Fukunaga et al., 1992) . However, the normal function of Fas in non-lymphoid tissues and its role during the genesis of solid tumors remain to be further elucidated. It has been previously shown that lpr mice (lacking functional Fas-receptors) in addition to pathologies related to the immune system, show an increased liver volume Golstein, 1995, 1996) and an abnormal, corni®ed vaginal epithelium (Suzuki et al., 1996) . Furthermore, most tissues that constitutively co-express Fas and FasL in the adult mouse are characterized by apoptotic cell turnover . These and other ®ndings suggest a critical implication of Fas-mediated apoptosis in tissue turnover. As dysregulation of tissue turnover is also a central issue in tumorigenesis, it is tempting to speculate that the Fas/FasL system may be crucially involved in tumor development. Indeed, loss of Fas expression or function has been demonstrated in various cancers including melanomas , colon cancer (Butler et al., 1998; Moller et al., 1994) , testicular cancer (Lebel et al., 1996) , hepatocellular carcinoma (Strand et al., 1996) , and acute myeoloblastic leukemia (Robertson et al., 1995) . In contrast, the levels of FasL are frequently up-regulated in many tumor tissues thus creating an immune privileged situation Strand et al., 1996; Walker et al., 1997) . Furthermore, it has recently been demonstrated that FasL-induced apoptosis is required to eciently eliminate DNAdamaged keratinocytes in the skin (Hill et al., 1999) . These data indicate that FasL-mediated apoptosis is important for skin homeostasis and suggest that dysregulation of Fas-FasL interactions on the aected cells are central to the development of skin cancer. In addition, these ®ndings raise the possibility that, at least in certain tissues, Fas activation may result in diminished tumorigenicity for reasons independent of the immune system. This may principally occur when the tumor cells express Fas constitutively, and when downstream Fas signaling is intact. As a consequence, suicidal or fratricidal elimination of tumor cells by apoptosis may occur.
We have recently demonstrated that oncogenic Ras (Ha-Ras) eciently down-regulates Fas expression both in cells of epithelial and ®broblastic origin, thus rendering these cells resistant to FasL-induced apoptosis (Peli et al., 1999) . As a continuation of this work we have now investigated as to how the Fas/FasL system alone may contribute to the tumorigenic potential of a given cell type. For this purpose we have employed NIH3T3 populations that show moderate Fas expression and develop into tumors after a certain latency period. To exclude the immune system these tumorigenicity assays have been performed in athymic nude mice, and in athymic nude/gld mice respectively.
These experiments have revealed that there is a strong selective pressure in vivo against Fas-expressing NIH3T3 cells, favoring survival, proliferation and eventually tumor formation by Fas-negative cells. Reexpression of Fas in tumorigenic NIH3T3 cells results in either the complete abolishment of tumor development, or in a large extenuation of the latency period of tumor growth. Most importantly, Fas-positive cells grown under suboptimal cell adhesion and/or limiting amounts of survival factors, become sensitized to FasL-induced caspase activation and thus undergo large-scale apoptosis, most likely by a suicide or fratricide mechanism. Based on these ®ndings, we conclude that Fas-dependent apoptosis may not only be initiated by a T cell-dependent immune response, but also upon sensitization to cell autonomous Fas signaling. The time period required to render a critical number of cells unresponsive to both these mechanisms may determine what is commonly referred to as the latency period of tumor outgrowth.
Results

Restoration of Fas expression reduces the tumorigenic potential
To investigate whether the Fas/FasL system is implicated in the regulation of apoptosis during tumor formation, we performed serial loss-gain experiments employing three groups of NIH3T3 cells that signi®cantly diered in their Fas expression levels. The ®rst group consisted of NIH3T3 cells (passage 11) which expressed relatively low levels of Fas (Figure 1a ). These cells, when subcutaneously injected into athymic nude mice, developed into palpable tumors after relatively long latency periods of 28 ± 33 days ( Figure   1b ). Consistently, upon addition of FasL these cells showed caspase activity of about 2.5-fold over background ( Figure 2a ) and about 50% of the cells underwent apoptotic cell death (Figure 2b ). The cells recovered from tumors formed by NIH3T3 cells, here designated NIH-exTumor cells (NIH-exTu cells), constitute the second group of cells studied. Unlike the parental NIH3T3 line these tumor-derived cells lacked detectable surface Fas expression (Figure 1a) . Upon re-injection into mice, NIH-exTu cells developed into palpable tumors almost as rapidly as Rastransformed clones did, which is within 7 ± 10 days after injection (Figure 1b) . Like Ha-Ras-transformed NIH3T3 cells, NIH-exTu cells turned out to be entirely resistant to FasL with respect to both caspase activity, and apoptotic cell death (Figure 2a,b) . These ®ndings suggests that loss of Fas expression may well be part of the selection process that allows a subset of Fasnegative tumor cells to survive and ®nally to constitute the tumor.
Employing retroviral gene transfer, we could restore Fas expression in parental NIH3T3 cells as well as in highly tumorigenic NIH-exTu cells (Figure 1a) . Thus, the third group to be studied consisted of NIH-Fas and NIH-exTu-Fas clones. These two types of Fasexpressing clones showed high caspase activity ( Figure  2a Similarly all of the NIH-exTu-Fas clones were clearly inhibited in their tumor-forming capacity. These clones, however, showed some clonal variation which apparently depended on the Fas expression levels. While NIH-exTu-Fas/clone 7 hardly ever formed tumors, clones 5, 6, 8, 9 and 10 eventually developed into palpable tumors between 35 and 60 days after injection (Figure 1b and data not shown). Notably, these cells, when recovered from tumors (NIH-exTuFas-exTu cells) consistently failed to express signi®cant levels of Fas (Figure 1a) , suggesting that here a potent selection mechanism led to the abolishment of even ectopically expressed Fas and/or eciently eliminated Fas-expressing cells. Thus, there was a clear correlation between FasLinduced caspase activity and cell death on the one hand, and the tumorigenic potential of the cells on the other. Interestingly, in the absence of exogenous FasL, caspase activities remained at background levels in all the cell clones tested (Figure 2a ). These ®ndings suggest that in vivo strong and rapid Fas activation depends on both suciently high Fas expression levels and the induction of cell bound FasL.
Ectopic Fas expression restores anchorage dependence
Upon detachment from their substrate, non-transformed cells usually undergo apoptosis, a phenomenon referred to as`anoikis ' (Frisch and Francis, 1994) . This control mechanism ensures that cells do not normally survive without adhesion to their speci®c extracellular matrix. One characteristic feature of tumor cells, however, is their capacity to circumvent this control mechanism and to survive within an inappropriate matrix or even without adhesion (as is the case when tumor cells are disseminated in the blood stream).
Based on our ®nding that the levels of Fas expression strictly correlated with the tumorigenic potential of the cells, we assayed their capacity to proliferate in an anchorage-independent fashion in semi-solid medium (soft agar). When seeded in soft agar, parental NIH3T3 cells (expressing moderate levels of Fas) formed both small and medium size colonies ( Figure  3a) , whereas Fas-negative, NIH-exTu cells, like Rastransformed NIH3T3 cells, developed into large, threedimensional aggregates (Figure 3b) . In contrast, NIHFas and NIH-exTu-Fas clones consistently remained as single cells which eventually (7 ± 15 days after plating) underwent apoptosis (Figure 3c,d) . Remarkably, these same cells did not show any signs of proliferationinhibition or cell death when grown on conventional cell culture plastic (data not shown). These ®ndings suggest that the sensitivity to Fas signaling may be modulated by environmental conditions, such as substrate adhesion. Since in these experiments exogenous FasL was absent, the most likely explanation for the induction of cell death is that cell-surface FasL and Fas interact to trigger death signaling in the cells on which they are both expressed. It should be noted, however, that this fratricide mechanism was slow and clearly less ecient than the apoptotic cell death induced by exogenously added FasL. To further demonstrate that survival in semisolid medium correlated inversely with Fas expression, NIH-exTu-Fas clones resistant to FasL were selected through prolonged culture in the permanent presence of FasL. These clones underwent apoptosis induced by UV and staurosporine, but readily formed colonies in soft agar in which no signs of apoptotic cell death were detectable (Figure 3e) . Notably, both NIH-exTu-Fas clones and NIH-Fas clones (data not shown) developed into large colonies in the presence of the caspase inhibitor zVAD.fmk (Figure 3f) , again indicating that Fas-induced death signaling is involved in regulating cell proliferation in semi-solid medium and anchoragedependence.
Host-derived FasL is not crucially involved in tumor suppression
To further elucidate the above mentioned ®nding that the Fas/FasL system may be also implicated in fratricide cell killing, we injected NIH3T3, NIH-exTu and NIH-exTu-Fas cells into nude C57B1/6 gld mice, which are genetically de®cient in functional FasL. These experiments revealed that in gld mice latency periods and tumor incidences did not signi®cantly dier from those observed in normal C57B1/6 nude mice (Figure 4a) . Thus, FasL produced by the tumor cells themselves was crucially involved in their elimination.
To further address this issue, FasL expression was analysed in the dierent NIH clones by RT ± PCR. In agreement with a previous report (Hueber et al., 1997) , NIH3T3 cells were found to express FasL, albeit at low levels ( Figure 4b ). These ®ndings implicate that NIH3T3 cells not only express Fas but also exhibit low levels of Fas ligand, raising the possibility that cellsurface Fas and FasL interact to trigger death of the cell on which they are both expressed.
The lack of cell adhesion or the absence of survival factors increase the sensitivity to Fas-dependent apoptosis Although exogenous FasL was absent in soft agar, the colony-preventing eect of ectopically expressed Fas was obvious. To further elucidate this issue, we determined caspase activities in the absence or presence of cell-substrate adhesion or survival factors in NIH, NIH-Fas, NIH-exTu and NIH-exTu-Fas cells. When plated on poly-HEMA coated cell culture dishes (on which cell-substrate adhesion is prevented) and in the presence of only 30 ng/ml FasL, for 4 h, all the Fasexpressing cell types tested, showed a signi®cant increase in caspase activities as compared to cells adherent on conventional cell culture plastic (twofold in parental NIH3T3 cells, ®vefold in NIH-Fas, eightfold in NIH-exTu-Fas clones ( Figure 5 ). In contrast, none of the Fas-negative, NIH-exTu cells showed increased caspase activities even after overnight exposure to 100 ng/ml FasL ( Figure 5 ).
Similar results were obtained upon withdrawal of survival factors (fetal calf serum, FCS). FasL-induced caspase activity was highly elevated in Fas expressing cells after 4 h in the absence of FCS and in the presence of 30 ng/ml FasL ( Figure 5 ). Furthermore, in these cells an increase of caspase activity, even in the absence of exogenous FasL, was evident ( Figure 5) . Notably, neither the lack of substrate nor limitation of survival factors in¯uenced the levels of Fas-receptor surface expression (data not shown).
These ®ndings suggest that environment cues, such as growth and survival factors and extracellular matrix components can considerably modulate the cell's sensitivity to Fas activation. The regulation of intracellular inhibitors such as c-FLIP (Irmler et al., 1997) , c-IAP (Deveraux et al., 1998; Wang et al., 1998) , TRAF1 and TRAF2 (Wang et al., 1998) , Bcl-2 (Shinoura et al., 1999; Srivastava et al., 1999) or FAP-1 (Ungefroren et al., 1998) may be crucial in this respect. Figure 5 The lack of cell adhesion or limited amounts of survival factors increase the sensitivity to Fas-dependent apoptosis. NIH3T3 cells and NIH-exTu cells, as well as their corresponding Fas expressing counterparts, were analysed for their sensitivity to recombinant FasL in the presence or absence of either substrate adhesion or survival factors (FCS). Note that even highly tumorigenic NIH-exTu clones upon re-expression of Fas and when grown in the absence of substrate or FCS are rendered highly sensitive to low amounts (30 ng/ml) of FasL. To avoid cell-substrate attachment, cells were plated on Poly-HEMA (2-Hydroxymethyl methacrylate) coated petri dishes Discussion Initiation of Fas-dependent apoptosis is a tightly regulated process which requires the presence of Fasligand, sucient Fas receptor to allow its cross-linking, and the down-regulation or inactivation of negative regulators of Fas-signaling.
One major ®nding of this paper is that environmental conditions which prevail during tumor development, such as the absence of (appropriate) substrates and/or limiting amounts of survival factors, can markedly modulate Fas-signaling and render cells hypersensitive to Fas-induced apoptosis. As a consequence, a selection process is initiated that greatly favors the survival of tumor cells that are resistant to Fas-mediated cell death. Resistance to Fas-induced apoptosis has indeed been demonstrated in various human tumors (Butler et al., 1998; Lebel et al., 1996; Moller et al., 1994; Robertson et al., 1995; Strand et al., 1996; Walker et al., 1997) . Most, if not all of these tumors, can be categorized into two groups. One group, consisting of cells that show greatly reduced (down-modulated) or abolished (mutated) Fas expression, and a second group which is constituted by cells that express Fas, but are de®cient in Fas-signaling. In this respect it is interesting to note that two recent publications provide evidence that overexpression of c-FLIP can eciently block Fas signaling and thus promote tumor growth (Djerbi et al., 1999; Medema et al., 1999) .
The exact molecular mechanisms regulating Fas signaling are currently only vaguely understood. In T cells, upregulation of FasL and downregulation of FLIP occur upon T cell receptor activation, thus inducing T cell clearance. We are proposing a similar model for adherent tumor cells whereby in the initial tumor the simultaneous expression of Fas and its ligand, in combination with a signi®cant increase in eciency of Fas signaling, can cause massive apoptosis. As a consequence, only cells that are de®cient in Fas expression (or Fas signaling) will be selected and eventually constitute the major tumor mass. This may also explain the survival and selection for tumor cells that are positive for FasL expression, and hence may create an immune privileged situation.
Our ®nding that the tumor-forming potential of Faspositive cells (NIH-Fas and NIH-exTu-Fas) is also signi®cantly reduced in nude C57B1/6 gld mice, which are de®cient in functional FasL, supports the notion that even in the absence of a T cell-dependent immune response, Fas expression can considerably interfere with tumor growth. This conclusion is further supported by our ®nding that colony formation in semi-solid medium (in which immune cells and thus exogenous FasL are absent) is also substantially suppressed upon restoration of Fas expression both in NIH and in highly tumorigenic NIH-exTu cells. These ®ndings suggest that there may be two dierent modes of Fas-induced cell death which may occur with dierent eciencies and in distinct biological situations. During tumorigenesis a T cell-dependent immune response may frequently be initiated and Fas-induced apoptosis of tumor cells may be rapid and ecient. However, under certain conditions, such as embryonal development and apoptotic cell turnover, Fas-dependent apoptosis most likely does not involve an immune response, but rather employs a fratricide or suicide mechanism. Our data are consistent with the idea that such a second mode of Fas-dependent apoptosis is also operational during tumorigenesis. It requires the simultaneous expression of Fas and FasL, the latter of which appears to be up-regulated by the speci®c stress conditions that prevail during tumorigenesis, such as the lack of appropriate cell adhesion and/or limiting amounts of survival factors (Faris et al., 1998) . Furthermore, these stress conditions may also largely increase the sensitivity of the tumor cells to the Fasmediated death signal.
This conclusion implicates that activation of certain growth factor receptors and integrins may signi®cantly modulate the ecacy of Fas signaling. This idea is in perfect agreement with our recent ®nding that PI3-kinase, activated by oncogenic Ha-Ras is markedly implicated in down-modulating Fas-expression, both in epithelial and ®broblastic cells (Peli et al., 1999) .
Taken together our studies suggest that the ecacy of Fas signaling in tumor cells are considerably increased by the lack of survival signals in the initial tumor micro environment. Thus, abrogating the gatekeeper function of the Fas/FasL system may well represent a rate-limiting step in the genesis of many (if not all) tumors which enables tumor cells to survive in an inappropriate environment and hence to invade other tissues. The critical involvement of Fas signaling in tumor formation underlines its importance in tissue homeostasis and prompts consideration of therapeutic strategies that aim at the restoration of Fas expression and/or Fas signaling.
Materials and methods
Cells and retroviral infection
NIH3T3 cells obtained from ATCC were maintained in DMEM containing 10% FCS. The murine Fas gene was introduced into both NIH3T3 and NIH-exTu cells via retroviral gene transfer. BOSC 23 packaging cells were employed to produce replication-defective, helper free retroviruses containing the pBabe-Fas-puro retroviral vector. For retroviral infection, both NIH3T3 and NIH-exTu cells were exposed for 2 h to virus containing supernatant. Infected clones were selected in G418 (1 mg/ml), isolated and expanded.
Tumorigenicity assays
Cells (5610 4 ) were suspended in 50 ml phosphate buered saline (PBS) and injected subcutaneously into the¯ank region of athymic nude mice or nude gld/gld mice. To re-isolate tumor cells for further propagation in tissue culture, the tumor tissue was cut into small pieces under sterile conditions using opposing scalpel blades and digested with 2 mg/ml collagenase Type 1 (Sigma) for 15 min at 378C. To remove remaining host cells, the tumor cells were cultured for 7 days in the presence of G418.
Soft agar assays
Anchorage-independent growth was determined by assessing the colony-forming eciency of cells suspended in soft agar. All experiments were conducted employing single cell suspensions containing 10 4 cells per 9.6 cm 2 well in semisolid medium consisting of 0.3% soft agar (Bacto-agar; Difco). This layer was poured on top of a bottom layer containing 0.5% agar. Fifteen days after plating, colony size was measured and documented. NIH-exTu-Fas-res cells that were resistant to FasL were generated culturing cells in the presence of 100 ng/ml enhanced sFasL (Alexis, San Diego, CA, USA) during 2 weeks. Surviving cells were cloned and analysed for Fas expression.
Expression of Fas
For FACS analysis, the anti-Fas antibody Jo2 conjugated to biotin (Pharmingen, San Diego, CA, USA) was used in combination with FITC-conjugated streptavidin (Dako, Glostrup, Denmark). Stained cells were analysed with a FACscan¯ow cytometer (Becton Dickinson, Mountain View, CA, USA). Cells stained only with FITC-conjugatedstreptavidin were used as control.
Generation of gld/nu mice C57B1/6 Bom-nu nude mice were purchased from Bomholtgard, Denmark. Nude gld/gld mice were generated by crossing C57B1/6 Bom-nu with C57BL/6 gld/gld mice (Jackson laboratory, Bar Harbor, MA, USA) and by subsequent intercrossing of heterozygous F1 animals.
Caspase activation assay
Cells (10 4 ) treated with enhanced sFasL (Alexis, San Diego, CA, USA) were lysed in 100 ml extraction buer. One mM uorogenic substrate (DEVD ± AMC; Alexis, San Diego, CA, USA) was added and incubated at room temperature for 2 h. Fluorophore release was measured by spectro¯uorometry at an excitation wavelength of 380 nm and an emission wavelength of 460 nm.
